Japanese Pharmacies Seek New Businesses As Competition Looms
This article was originally published in PharmAsia News
Japan's drugstores are looking for other markets as they anticipate a saturated market at home in the wake of new government deregulations. Many already are expanding the types of wares they sell or affiliating with large retailers. The pharmacies face a change in the law effective next spring when outlets other than pharmacies, such as department stores, are allowed to sell pharmaceuticals. Pharmacies see expansion into other markets as necessary because they would no longer be able to survive on sales of medicines alone. (Click here for more - a subscription may be required
You may also be interested in...
Teligent has achieved a “pivotal step in our journey toward securing a strong financial future,” according to management, after recapitalizing its significant debt burden and gaining access to more cash.
Pfizer has entered into an agreement with Premier to supply five essential medications to US healthcare providers through Premier’s ProvideGx program. Both companies aim to secure supply of products specifically used by COVID patients.
Announcing his “first step to take on pricing of generic drugs,” billionaire Mark Cuban recently associated his name with a new US generics company “to show that capitalism can be compassionate.” In an exclusive chat with Generics Bulletin, the newly established company’s CEO Alex Oshmyansky revealed that they started working on the company “in stealth” since 2018.